British Columbia Investment Management Corp Incyte Corp Transaction History

British Columbia Investment Management Corp

$15.9 Billion
Q4 2024

A detailed history of British Columbia Investment Management Corp transactions in Incyte Corp stock. As of the latest transaction made, British Columbia Investment Management Corp holds 31,337 shares of INCY stock, worth $2.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

31,337

Previous 27,158 15.39%

Holding current value

$2.26 Million

Previous $1.8 Million 20.56%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$65.08 - $83.38 $271,969 - $348,445	4,179 Added 15.39%	31,337 $2.16 Million
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $170,327 - $203,840	-2,971 Reduced 9.86%	27,158 $1.8 Million
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $378,885 - $471,941	7,403 Added 32.58%	30,129 $1.83 Million
Q1 2024 May 14, 2024	BUY	$56.55 - $66.59 $45,918 - $54,071	812 Added 3.71%	22,726 $1.29 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $251,932 - $310,037	4,830 Added 28.27%	21,914 $1.38 Million
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $20,662 - $25,597	339 Added 2.02%	17,084 $1.06 Million
Q4 2022 Feb 10, 2023	SELL	$67.18 - $84.11 $113,735 - $142,398	-1,693 Reduced 9.18%	16,745 $1.34 Million
Q3 2022 Nov 10, 2022	SELL	$66.18 - $82.86 $216,342 - $270,869	-3,269 Reduced 15.06%	18,438 $1.23 Million
Q2 2022 Aug 12, 2022	SELL	$66.18 - $83.18 $481,724 - $605,467	-7,279 Reduced 25.11%	21,707 $1.65 Million
Q1 2022 May 12, 2022	SELL	$66.02 - $79.71 $261,835 - $316,129	-3,966 Reduced 12.04%	28,986 $2.3 Million
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $98,683 - $115,463	-1,558 Reduced 4.51%	32,952 $2.42 Million
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $8,652 - $10,586	-126 Reduced 0.36%	34,510 $2.37 Million
Q2 2021 Aug 09, 2021	BUY	$79.87 - $87.53 $330,821 - $362,549	4,142 Added 13.58%	34,636 $2.91 Million
Q1 2021 Apr 30, 2021	SELL	$76.02 - $100.5 $63,324 - $83,716	-833 Reduced 2.66%	30,494 $2.48 Million
Q4 2020 Feb 02, 2021	SELL	$80.74 - $97.7 $57,971 - $70,148	-718 Reduced 2.24%	31,327 $2.73 Million
Q3 2020 Nov 10, 2020	BUY	$85.07 - $109.69 $214,206 - $276,199	2,518 Added 8.53%	32,045 $2.88 Million
Q2 2020 Aug 12, 2020	BUY	$74.18 - $108.93 $704,635 - $1.03 Million	9,499 Added 47.43%	29,527 $3.07 Million
Q1 2020 May 13, 2020	SELL	$63.18 - $85.97 $1.46 Million - $1.98 Million	-23,049 Reduced 53.51%	20,028 $1.47 Million
Q4 2019 Feb 12, 2020	BUY	$73.04 - $95.72 $1.32 Million - $1.74 Million	18,138 Added 72.73%	43,077 $3.76 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $1.38 Million - $1.64 Million	-18,931 Reduced 43.15%	24,939 $1.85 Million
Q2 2019 Aug 12, 2019	SELL	$73.52 - $88.7 $1.66 Million - $2 Million	-22,537 Reduced 33.94%	43,870 $3.73 Million
Q1 2019 May 08, 2019	BUY	$63.56 - $88.17 $1.33 Million - $1.84 Million	20,895 Added 45.91%	66,407 $5.71 Million
Q4 2018 Feb 13, 2019	BUY	$58.5 - $69.94 $344,857 - $412,296	5,895 Added 14.88%	45,512 $2.89 Million
Q3 2018 Nov 13, 2018	SELL	$61.75 - $74.23 $893,954 - $1.07 Million	-14,477 Reduced 26.76%	39,617 $2.74 Million
Q2 2018 Aug 09, 2018	SELL	$60.85 - $83.98 $1.54 Million - $2.12 Million	-25,301 Reduced 31.87%	54,094 $3.62 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $26,163 - $31,808	-315 Reduced 0.4%	79,395 $6.62 Million
Q4 2017 Feb 20, 2018	BUY	$93.56 - $116.6 $876,750 - $1.09 Million	9,371 Added 13.32%	79,710 $7.55 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $7.68 Million - $9.73 Million	70,339	70,339 $8.21 Million

Others Institutions Holding INCY

# of Institutions

706

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account

British Columbia Investment Management Corp Incyte Corp Transaction History